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Chronotropic Incompetence in Heart Failure
The relationship between heart rate (HR) during exercise and
exercise capacity in patients with heart failure due to left ventric-
ular systolic dysfunction remains unclear. The accepted diagnostic
criterion for chronotropic incompetence (CI), a maximum age-
predicted heart rate (MA-PHR) 85%, is seen in 50% of patients
with severe heart failure on contemporary medical therapy (1).
Whether the lesser HR rise is the cause of the exercise impairment
is less certain: as HR increases as a function of exercise load, it is
inevitable that HR at peak exercise will be lower in subjects with
worse exercise capacity.
Tse et al. (2) are to be congratulated in trying to explore these
issues in their study of patients with cardiac resynchronization
devices. However, some important issues were raised by their
suggestion that rate-adaptive pacing might be more widely used in
patients with resynchronization devices. In patients with the most
severe CI, defined as failure to reach 70% of age-predicted
maximum HR (n  11), Tse et al. were able to demonstrate an
increase in exercise capacity with rate-adaptive pacing. There are
no published data on the incidence of their chosen value of 70%,
although it was seen in 28% of patients in our dataset (1).
At first sight, this seems a useful incremental benefit. However,
using the more widely accepted definition of failure to achieve 85%
of age-predicted maximal HR (3), there was no benefit of rate
response pacing. In fact, in one-third of patients with less severe CI
(MA-PHR 70% to 85%), there was a reduction in exercise capacity
with rate response pacing.
Although CI in chronic heart failure (CHF) patients not taking
beta-blockers predicts a worse prognosis (1), lower HRs at rest are
associated with improved outcomes in beta-blocker–treated indi-
viduals (4). We have also previously demonstrated that HR
lowering by aggressive use of beta-blockers does not reduce
exercise capacity (1,5). Hence, the issue of CI in patients with
severe CHF is not resolved. Furthermore, the long-term effects of
rate response pacing and the consequent higher average HR on
mortality and left ventricular function are unknown. It is too early
to suggest that patients undergoing CRT should have their device’s
rate response function active.
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REPLY
We thank Drs. Witte and Clark for their interest in our study (1).
We agree with their comment that there is no established
diagnostic criterion for chronotropic incompetence (CI) for pa-
tients with heart failure (HF). The commonly used definition of
the age-predicted heart rate (HR) to diagnose CI is traditionally
employed for patients with ischemic heart disease. Despite the
wide application of rate-adaptive pacing, there is also no estab-
lished definition of CI for pacemaker patients (2). From a pacing
standpoint, the detection of CI is clinically relevant only when
there is a functional improvement associated with rate-adaptive
pacing. Prior studies have shown that HF patients with CI have
lower peak oxygen consumption as compared with those without
CI (3). Our data demonstrate that the conventional definition of
CI is not applicable to patients with HF implanted with cardiac
resynchronization therapy (CRT). Indeed, rate-adaptive pacing
was found to be beneficial only in those patients with severe CI
who failed to achieve 70% of age-predicted HR, and potentially
harmful to patients with mild CI based on the conventional
definition. Furthermore, the incidence of CI in HF patients
implanted with CRT appears to be higher than for those reported
in the general HF population (4). We have evaluated a total of 28
patients and have enrolled 20 patients (71%) with age-predicted
HR 85% for this study. This is likely because the current CRT
patients have more severe HF (class III to IV) and advanced
conduction system abnormalities as compared with the general HF
population.
As mentioned by Drs. Witte and Clark, a lower HR at rest
predicts better outcome in patients treated with a beta-blocker.
The use of rate-adaptive pacing only increases HR during exercise,
but not the resting HR, and the increase in 24-h HR due to
rate-adaptive pacing is minimal. In fact, the use of rate-adaptive
pacing can alleviate the CI to allow more aggressive use of
beta-blockers. Consistent with the findings in their recent studies
(4), we have shown that the percentage of HR changes during
exercise positively correlated with peak oxygen consumption (1).
We believe that our data have demonstrated that rate-adaptive
pacing is complementary to the use of CRT and optimal medical
therapy, including beta-blocker, to improve exercise capacity in
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